Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.

Disturbances in Heart Rhythm

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hands as diagnostic tools in medicine: should physicians touch their patients?

Arquivos brasileiros de cardiologia·2013

Same author

Brazilian contribution to a better understanding of geriatric cardiology.

Journal of geriatric cardiology : JGC·2012

Same author

[II Guidelines of Brazilian Society of Cardiology in geriatric cardiology].

Arquivos brasileiros de cardiologia·2010

Same author

[Off-pump myocardial revascularization in the elderly: analysis of morbidity and mortality].

Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular·2008

Same author

Cardiac papillary fibroelastoma and stroke in a young man--etiology and treatment.

Cerebrovascular diseases (Basel, Switzerland)·2008

Same author

Chagas' disease and the use of implantable cardioverter-defibrillators in Brazil.

The American journal of geriatric cardiology·2006

Search research articles

Related Experiment Video

Updated: May 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Atrial fibrillation in the elderly.

Roberto A Franken¹, Ronaldo F Rosa, Silvio Cm Santos

¹Department of Internal Medicine, Santa Casa São Paulo Medical School, R.Dr.Franco da Rocha 163/52, São Paulo 05015-040, Brazil.

Journal of Geriatric Cardiology : JGC

|August 24, 2012

Summary

This review covers atrial fibrillation management in the elderly, focusing on preventing thromboembolism and treatment options like rhythm or rate control. It also details new therapies including ablation and novel anticoagulants.

Keywords:

Atrial fibrillation Heart failure Prevention Thrombo-embolism Treatment

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Related Experiment Videos

Last Updated: May 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Area of Science:

Cardiology
Geriatrics

Background:

Atrial fibrillation presents a significant thromboembolic risk, particularly in the elderly population.
Current guidelines from the Brazilian Society of Cardiac Arrhythmias and Brazilian Cardiogeriatrics provide a framework for management.

Purpose of the Study:

To review atrial fibrillation management in the elderly based on Brazilian guidelines.
To emphasize thromboembolism prevention and discuss treatment strategies.
To present novel therapeutic approaches for atrial fibrillation.

Main Methods:

Review of existing guidelines and literature on atrial fibrillation.
Discussion of thromboembolic risk assessment and prevention strategies.
Analysis of rhythm control versus rate control in elderly patients.
Overview of emerging treatments such as radiofrequency ablation and new anticoagulants.

Main Results:

Atrial fibrillation poses a substantial risk of stroke and systemic embolism.
Management strategies prioritize individualized care balancing anticoagulation and arrhythmia control.
Novel oral anticoagulants (NOACs) and radiofrequency ablation offer advanced treatment options.

Conclusions:

Effective management of atrial fibrillation in the elderly requires a comprehensive approach focusing on stroke prevention.
Both rhythm and rate control strategies are viable, with treatment decisions tailored to individual patient profiles.
Emerging therapies are expanding the options for treating atrial fibrillation, improving patient outcomes.